Inter-Reader Variability Using PI-RADS v2 Versus PI-RADS v2.1: Most New Disagreement Stems from Scores 1 and 2

被引:4
|
作者
Beetz, Nick Lasse [1 ]
Haas, Matthias [1 ]
Baur, Alexander [1 ]
Konietschke, Frank [2 ]
Roy, Akash [3 ]
Hamm, Charlie Alexander [1 ]
Rudolph, Madhuri Monique [1 ]
Shnayien, Seyd [1 ]
Hamm, Bernd [1 ]
Cash, Hannes [4 ]
Asbach, Patrick [1 ]
Penzkofer, Tobias [1 ]
机构
[1] Charite, Dept Radiol, Berlin, Germany
[2] Charite, Dept Biometry & Clin Epidemiol, Berlin, Germany
[3] Duke Univ, Biostat & Bioinformat, Sch Med, Durham, NC USA
[4] Charite, Dept Urol, Berlin, Germany
关键词
PI-RADS v2; 1; mpMRI; prostate cancer; inter-reader agreement;
D O I
10.1055/a-1752-1038
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose To analyze possible differences in the inter-reader variability between PI-RADS version 2 (v2) and version 2.1 (v2.1) for the classification of prostate lesions using multiparametric MRI (mpMRI) of the prostate. Methods In this retrospective and randomized study, 239 annotated and histopathologically correlated prostate lesions (104 positive and 135 negative for prostate cancer) were rated twice by three experienced uroradiologists using PI-RADS v2 and v2.1 with an interval of at least two months between readings. Results were tabulated across readers and reading timepoints and inter-reader variability was determined using Fleiss kappa (kappa). Thereafter, an additional analysis of the data was performed in which PI-RADS scores 1 and 2 were combined, as they have the same clinical consequences. Results PI-PI-RADS v2.1 showed better inter-reader agreement in the peripheral zone (PZ), but poorer inter-reader agreement in the transition zone (TZ) (PZ: kappa = 0.63 vs. kappa = 0.58; TZ: kappa = 0.47 vs. kappa = 0.57). When PI-RADS scores 1 and 2 were combined, the use of PI-RADS v2.1 resulted in almost perfect inter-reader agreement in the PZ and substantial agreement in the TZ (PZ: kappa = 0.81; TZ: kappa = 0.80). Conclusion PI-RADS v2.1 improves inter-reader agreement in the PZ. New differences in inter-reader agreement were mainly the result of the assignment of PI-RADS v2.1 scores 1 and 2 to lesions in the TZ. Combining scores 1 and 2 improved inter-reader agreement both in the TZ and in the PZ, indicating that refined definitions may be warranted for these PI-RADS scores.
引用
收藏
页码:852 / 861
页数:10
相关论文
共 50 条
  • [41] Comparison of PI-RADS version 2.1 and PI-RADS version 2 regarding interreader variability and diagnostic accuracy for transition zone prostate cancer
    Lili Xu
    Gumuyang Zhang
    Daming Zhang
    Xiaoxiao Zhang
    Xin Bai
    Weigang Yan
    Yi Zhou
    Zhien Zhou
    Yu Xiao
    Zhengyu Jin
    Hao Sun
    Abdominal Radiology, 2020, 45 : 4133 - 4141
  • [42] Magnetic Resonance Elastography Combined With PI-RADS v2.1 for the Identification of Clinically Significant Prostate Cancer
    Chen, Jie
    Chen, Yuntian
    Chen, Guoyong
    Deng, Liping
    Yuan, Yuan
    Tang, Hehan
    Zhang, Zhen
    Chen, Tingyu
    Zeng, Hao
    Yuan, Enyu
    Yin, Meng
    Chen, Jun
    Song, Bin
    Yao, Jin
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2024,
  • [43] PI-RADS v2 may help predicting clinical significant cancer preoperatively
    Kurose, Kyohei
    Moriwake, Takatoshi
    Hata, Kazuhiro
    Kishi, Mikio
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 450 - 450
  • [44] 前列腺影像报告和数据系统(PI-RADS V2.1)解读
    王良
    中华放射学杂志, 2020, (04) : 273 - 274-275-276-277-278
  • [45] PI-RADS v2.1 evaluation of prostate “nodule in nodule” variants: clinical, imaging, and pathological features
    MingHua Sun
    Li Xu
    XiaoYan Zhang
    LiYu Cao
    WenBao Chen
    Kai Liu
    Hao Wu
    DongDong Xie
    Insights into Imaging, 15
  • [46] Interobserver agreement of Prostate Imaging–Reporting and Data System (PI-RADS–v2)
    Hala Maher Ahmed
    Ahmed Ebrahim Ebeed
    Ahmed Hamdy
    Mohamed Abou El-Ghar
    Ahmed Abdel Khalek Abdel Razek
    Egyptian Journal of Radiology and Nuclear Medicine, 52
  • [47] PI-RADS v2.1 evaluation of prostate "nodule in nodule" variants: clinical, imaging, and pathological features
    Sun, MingHua
    Xu, Li
    Zhang, XiaoYaN
    Cao, LiYu
    Chen, WenBao
    Liu, Kai
    Wu, Hao
    Xie, DongDong
    INSIGHTS INTO IMAGING, 2024, 15 (01)
  • [48] Assessment of PI-RADS v2 categories ≥ 3 for diagnosis of clinically significant prostate cancer
    Nayana U. Patel
    Kimberly E. Lind
    Kavita Garg
    David Crawford
    Priya N. Werahera
    Sajal S. Pokharel
    Abdominal Radiology, 2019, 44 : 705 - 712
  • [49] Validation of dominant and secondary sequence utilization in PI-RADS v2 for classifying prostatic lesions
    Soodana-Prakash, Nachiketh
    Castillo, R. Patricia
    Reis, Isildinha M.
    Stoyanova, Radka
    Kwon, Deukwoo
    Velasquez, Maria C.
    Nahar, Bruno
    Kannabur, Pratik
    Johnson, Taylor A.
    Swain, Sanjaya K.
    Ben-Yakar, Natalie
    Venkatramani, Vivek
    Ritch, Chad
    Satyanarayana, Ramgopal
    Gonzalgo, Mark L.
    Parekh, Dipen J.
    Bittencourt, Leonardo
    Punnen, Sanoj
    CANADIAN JOURNAL OF UROLOGY, 2019, 26 (03) : 9763 - 9768
  • [50] ASSESSMENT OF CLINICAL UTILITY OF PSA DENSITY IN RISK STRATIFICATION OF PI-RADS V2.1 CATEGORIES ON PROSTATE MRI
    Giannarini, Gianluca
    Girometti, Rossano
    Panebianco, Valeria
    Maresca, Silvio
    Cereser, Lorenzo
    De Martino, Maria
    Pizzolitto, Stefano
    Ficarra, Vincenzo
    Zuiani, Chiara
    Valotto, Claudio
    JOURNAL OF UROLOGY, 2022, 207 (05): : E959 - E960